Print Page   |   Contact Us   |   Sign In   |   Join Now
Andrew Zhang
Share |

Andrew Zhang is an Associate Principal Scientist in the Chemical Biology Group at AstraZeneca. He joined AstraZeneca in 2013 with research interests in target deconvolution, particularly using chemical proteomics and orthogonal methods for identifying targets, profiling selectivity, and confirming engagement. Previously, he has conducted research at the interface between small molecules and antibodies, on small molecule immunomodulators as well as antibody-drug conjugates. He obtained a Bachelors of Science degree in Chemistry and a Bachelors of Arts degree in Molecular and Cell Biology from the University of California, Berkeley, and completed his PhD training with Professor David Spiegel at Yale University. Prior to joining AstraZeneca, he spent one year in the Drug Discovery Program at the Ontario Institute for Cancer Research (Toronto, Canada) as a postdoctoral fellow.

Association Management Software  ::  Legal